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Background: Frail hospitalized older adults are at risk for adverse outcomes. Previous studies have
suggested beneﬁts for inpatient geriatric management (GEM). We sought to determine whether hospi-
talized patients with a history of heart failure (HF) beneﬁtted from inpatient GEM or not.
Methods: We studied 309 inpatients previously diagnosed with HF who were participants in a random-
ized trial of geriatric evaluation and management (GEM) versus usual care (UC). The intervention
involved multidisciplinary teams that provided comprehensive geriatric assessment. We evaluated
health-related quality of life (HRQOL), basic activities of daily living (ADLs), health service utilization, and
survival at discharge, 6 months, and 1 year post randomization.
Results: GEM patients had higher mean change scores for physical function (unadjusted means:
0.17 vs. e4.67, p ¼ 0.046) and basic ADLs (1.25 vs. 0.67, p ¼ 0.003) at hospital discharge, which remained
signiﬁcant after adjusting for baseline HRQOL scores and in-hospital days. Outcomes were not signiﬁ-
cantly different at 1 year. Length of stay for GEM was greater than UC (24 days vs. 17 days, p ¼ 0.03), but
total costs at 1 year were not different (p ¼ 0.9). Mortality rates at 1 year were high and similar (GEM
29.0%, UC 27.3%, p ¼ 0.73) in both the groups.
Conclusion: Inpatient GEM was associated with better maintenance of physical function and basic ADLs at
hospital discharge; however, no differences in HRQOL or survival were observed between GEM and UC at
1 year post randomization. Restructuring inpatient care models to incorporate inpatient GEM principles
may be one method to optimize health-care delivery.
Copyright  2012, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Frail older adults hospitalized for acute illness are vulnerable to
adverse in-hospital and intermediate term outcomes1e3. It has
been shown that up to 23% of patients have functional decline priorerest.
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iwan Society of Geriatric Emergento hospitalization, which does not return to baseline by the time of
hospital discharge4. Prevalence of heart failure (HF) in frail older
adults can be up to 30% among hospitalized patients5, and, given
the associated comorbidities, costs, and diminished quality of life of
patients with HF, efforts to optimize care in this population are
needed6. Similar to positive outcomes observed from outpatient
disease management programs that emphasize adherence and
behavioral modiﬁcations6,7, care designed around core geriatric
principles in hospitalized older adults, when compared to tradi-
tional (inpatient) care models, has been shown to improve func-
tional independence and reduce institutionalization at the time of
hospital discharge8,9. Given the emphasis on health prevention
through modifying behavior and implementing multidisciplinary
intervention, comprehensive geriatric assessment applied to inpa-
tient care may have unique advantages in frail older adults with
a history of HF7,10e14.
Geriatric evaluation and geriatric management (GEM) has
been used over the past two decades to identify frail elders at
high risk for functional decline and to develop targeted interventioncy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
Geriatric Inpatient Units and Heart Failure 113programs to arrest or reduce the trajectory of decline15,16. Key
elements of GEM include identifying risk for falls, pharmacologic
optimization, evaluating cognitive and affective status, assessing
nutrition, and identifying social support and community resources12.
In a randomized controlled trial of inpatient and outpatient
GEM versus usual care (UC), positive outcomes on several health
domains and functional status in frail adults were observed with
GEM9. However, whether such a strategy could also beneﬁt
patients with previously diagnosed HF is unknown. Therefore, we
hypothesized that a model of care utilizing inpatient GEM in
acutely hospitalized frail adults with chronic HF may be associated
with improvements in important health outcomeswhen compared
to UC.
2. Methods
This study was a secondary analysis of 309 inpatients from
the Veterans Administration (VA) Cooperative study entitled “A
Controlled Trial of Inpatient and Outpatient Geriatric Evaluation
and Management9.” The parent trial was a VA multicenter 2  2
factorial study, randomizing 1388 participants to an inpatient GEM
or an inpatient UC, and, upon hospital discharge, to either geriatric
outpatient clinic or usual outpatient care. The details of the parent
trial have previously been described9. Brieﬂy, patients were
enrolled between August 1995 and January 1999, and stratiﬁed
randomization occurred within site and level of functional status.
Research assistants at each site identiﬁed eligible patients accord-
ing to prespeciﬁed criteria: age 65 years and hospitalized on
a medical or surgical ward with an expected length of stay2 days.
2.1. Study population
HF patients were classiﬁed as such based on a prior clinical
documentation of HF in the medical record. The history of HF had
been recognized and documented by a health-care provider on
clinical grounds, irrespective of left ventricular function. In addi-
tion, a corresponding International Classiﬁcation of Diseases, 9th
Revision (ICD-9) code for HF, was present in the medical record.
Eligible patients also had to be frail, deﬁned as having at least
two of the following characteristics: inability to perform one or
more basic activities of daily living (ADLs), a stroke within the
previous 3 months, a history of falls, difﬁculty walking, malnutri-
tion, dementia, depression, one or more unplanned admissions in
the previous 3 months, prolonged bed rest, or incontinence. These
target criteria were selected to capture patients most likely to
beneﬁt from a program of GEM17,18. Patients were excluded if they
were admitted from a nursing home, had previously been hospi-
talized in an inpatient GEM, were currently enrolled in another
clinical trial, had a severe disabling disease or terminal condition or
severe dementia, did not speak English, lacked access to a tele-
phone for follow-up, or were unwilling or unable to return for
follow-up for any reason. Finally, the Charlson comorbidity index
was calculated for trial participants19.
2.2. Inpatient geriatric intervention versus UC
The geriatric intervention consisted of core multidisciplinary
teams providing GEM according to VA standards and consistent
with care guidelines20. The inpatient and outpatient teammembers
included a geriatrician, a nurse, and a social worker, who followed
standard protocols for GEM. Speciﬁc instructions included obtain-
ing a history and performing a physical examination; screening for
geriatric syndromes; assessing functional, cognitive, affective, and
nutritional status; evaluating the primary caregiver’s capabilities;
and assessing the patient’s social situation. After formulation ofthe treatment plan, the multidisciplinary teamwould meet at least
twice a week to review the plan.
Inpatients randomized to UC received all standard diagnostic
studies and treatment approaches as appropriate for the medical
condition that prompted hospitalization. However, the distinguish-
ing feature between UC and GEM was the absence of the multidis-
ciplinary approach for geriatric evaluation and management to
patients in the UC group.
2.3. Outcomes
Outcomes for this study included the primary and secondary
outcomes from the parent trial, which were survival and health-
related quality of life (HRQOL)9. The primary outcome for our
analysis was the subscale score for physical function as measured
by the Medical Outcomes Study 36-Item Short-Form General
Health Survey (SF-36)21,22. Scores on the SF-36 were scaled such
that, for each item, higher scores reﬂected improved functioning.
The secondary study outcomes included the remaining subscales of
the SF-36 and functional status as measured by basic and instru-
mental ADLs23. The scale for the basic six-item Katz ADL measure
included bathing, dressing, toileting, transferring, feeding, and
continence, with a score of 1 for independent functioning on each
domain and a maximal score of 624. The scale for instrumental ADL
included meal preparation, housecleaning, medication manage-
ment, performing ﬁnancial management, driving or arranging for
transportation, telephone use, and shopping with a score of 1 for
independent functioning on each and a maximal score of 9. Health
services use and costs were other secondary outcomes that were
measured by information collected from the decentralized
computer at each center, centralized VA databases, and Medicare
databases. Research assistants recorded all data on predesignated
forms during hospitalization. Data obtained during hospitalization
included baseline characteristics and changes in HRQOL and ADLs.
Follow-up outcome data, including HRQOL, ability to perform ADLs,
and vital status, were gathered via telephone calls conducted by
a research assistant based in Durham, NC, blinded to the patient’s
treatment assignment. Both face-to-face and telephone-based data
collection for the SF-36 have previously been shown to have high
concordancewith one another25. Data collected at the participating
research sites were faxed directly to the coordinating center.
Follow-up informationwas obtained after discharge and at 6 and 12
months post randomization.
2.4. Statistical analysis
The primary study objective involved assessing the efﬁcacy
of inpatient GEM versus UC on the primary and secondary
outcomes of 309 participants with a prior diagnosis of HF. Since
this study involved the evaluation of outcomes (postdischarge
and 1 year) among hospitalized older adults with a history of
HF by management strategy, we limited our analysis of GEM or
UC to inpatients only. We then tested the change in HRQOL and
ADLs from baseline (prerandomization) to (1) discharge from
the inpatient episode, (2) 6 months from baseline, and (3) 12
months from baseline. Arm differences in continuous outcomes
were tested with the general linear model, with the general
form of: Y(discharge, 6 months, or 12 months) e Y(baseline) ¼ Y(baseline) þ
Arm(GEMU or UC) þ Number of days of the inpatient episode. While
physical function was the primary outcome, group differences in
nine secondary outcomes were also tested. The alpha level for these
tests was controlled at an overall two-sided level of 0.05 using
the procedure by Holm26. We considered each time point
(discharge, 6 months, and 1 year) separately when applying the
Holm procedure. The continuous outcomes included SF-36 HRQOL
Table 2
Mean change from randomization to discharge, 6 months, and 1 year for patients
with a history of HF by treatment arm.a
SF-36 subscales Usual care
inpatient
GEM
inpatient
pb Holm
procedure
a levelc
Physical functioning D/C 4.7 0.17 0.046 N/A
S.M. Gharacholou et al.114subscale scores, basic ADL scores, and instrumental ADL scores as
assessed at prerandomization, discharge, and 6- and 12-month
follow-up. Mortality was assessed using nonparametric log-rank
survival analysis, after subtracting the number of days spent in
the index inpatient episode from the days at risk for death. Total
costs included all costs of inpatient, outpatient, and long-term care
provided by Veterans Affairs medical centers, including care in
private nursing homes. Costs of inpatient and outpatient care at
non-Veterans Affairs facilities were not included in the analysis of
total costs. As there were no baseline cost values to consider and
because total costs were highly correlated with inpatient length of
stay, costs were treated separately from the other outcomes in this
study. The unadjusted bivariate test for total costs by arm was
evaluated using a t test after a log transformation due to the non-
normal distribution, and corroborated by using the Wilcoxon
rank-sum test. A p value of <0.05 was considered statistically
signiﬁcant for all tests, except for the utilization of the Holm
procedure, as mentioned above. All analyses were performed using
SAS version 9.1 (SAS Institute, Inc., Cary, NC, USA).
3. Results
From the 1388 study participants enrolled in the original trial,
we identiﬁed 309 patients with a previous diagnosis of HF by ICD-9
codes. Table 1 shows the baseline characteristics of the hospitalized
participants by treatment group. Patients were similar with respect
to baseline demographic characteristics, including age, race,Table 1
Baseline characteristics of the 309 HF patients.
Characteristics Usual care
inpatient
(n ¼ 154)
GEM
inpatient
(n ¼ 155)
p
Age 74.4  5.9 74.3  6.0 0.95
Age 74, n (%) 77 (50.0) 84 (54.2) 0.46
Marital statusdmarried, n (%) 92 (60.4) 87 (56.1) 0.45
RacedWhite, n (%) 113 (73.4) 119 (76.8) 0.49
Educationdhigh-school graduate, n (%) 68 (44.2) 71 (45.8) 0.77
Admitting servicedmedicine, n (%) 133 (86.4) 121 (78.1) 0.06
Chronic pulmonary disease, n (%) 68 (44.2) 65 (41.9) 0.69
Cerebrovascular disease, n (%) 40 (26.0) 34 (21.9) 0.41
Peripheral vascular disease, n (%) 34 (22.1) 45 (29.0) 0.16
Myocardial infarction, n (%) 42 (27.3) 55 (35.5) 0.12
Dementia, n (%) 11 (7.1) 10 (6.5) 0.81
Comorbidity (Charlson score)d meana 3.73  2.05 3.86  1.98 0.57
SF36 subscalesb
Physical function 24.5  23.9 18.9  21.7 0.03
Physical limitations 16.6  30.9 11.1  22.8 0.08
Emotional limitation 64.7  43.8 60.5  44.0 0.40
Bodily pain 44.5  30.5 41.3  28.6 0.33
Energy/fatigue 33.3  24.2 30.0  21.3 0.21
Mental health 67.0  22.7 60.0  24.8 0.01
Social activity 49.8  32.5 52.7  34.3 0.45
General health 28.1  24.7 28.0  21.9 0.98
ADL scoresc
ADL basic 3.3  2.2 3.2  2.1 0.49
ADL instrumental 4.0  2.8 4.3  2.5 0.22
Data are presented as mean  SD or %.
ADL ¼ activity of daily living; GEM ¼ geriatric management; HF ¼ heart failure;
SD ¼ standard deviation; SF-36 ¼ Medical Outcomes Study 36-Item Short-Form
General Health Survey.
a The comorbidity index indicates the number and severity of coexisting condi-
tions, on a scale from 0 to 34, with higher scores indicative of greater comorbidity.
b Scores on the SF-36 were adjusted so that, for each item, higher scores indicate
better functioning.
c The scale for basic ADLs included six items, with a score of 1 for independent
functioning on each and a maximal score of 6. The scale for instrumental ADL was
a nine-item one (maximal score of 9), with a score of 1 for independent functioning
on each.educational achievement, admitting service, and comorbid illness.
In addition, most parameters related to the SF-36 measures were
also similar at baseline, with the exception of physical function
(p ¼ 0.03) and mental health (p ¼ 0.01) (Table 1). The ability to
perform basic and instrumental ADLs was also noted to be similar
between study groups at baseline. After adjusting for the number of
in-hospital days and mean SF-36 subscale scores at baseline in the
two treatment arms, patients who had been randomized to inpa-
tient GEM had less decline in physical function and basic ADLs at
the time of hospital discharge compared to those randomized to
UC (Table 2), the latter even in comparison to the adjusted Holm p
value. At 6 months and 1 year post randomization, the beneﬁts of
inpatient GEM in domains of basic ADLs and physical function seen
at hospital discharge were no longer observed (Table 2), and hence
no need to invoke the corrected Holm p values. The favorable trends
observed in the SF-36 subscale scores at discharge and at 1 year for
patients in the inpatient GEM group compared to those in the
inpatient UC group were noted, but none of these reached statis-
tical signiﬁcance. There were no observed HRQOL outcomes for6 mo 3.3 2.64 0.45
12 mo 1.5 3.3 0.61
Bodily pain D/C 9.8 11.1 0.74 0.0083
6 mo 8.0 11.9 0.63
12 mo 19.0 15.5 0.37
Vitality D/C 2.5 2.2 0.90 0.0167
6 mo 0.4 0.6 0.70
12 mo 0.8 0.4 0.69
Physical role D/C 5.1 6.0 0.79 0.0125
6 mo 16.8 24.2 0.26
12 mo 23.6 25.0 0.77
General health D/C 6.3 5.5 0.74 0.0071
6 mo 6.5 6.4 0.93
12 mo 6.4 6.7 0.92
Social functioning D/C 0.7 1.3 0.60 0.0063
6 mo 4.7 5.9 0.20
12 mo 8.8 13.7 0.27
Emotional role D/C 10.5 9.2 0.78 0.01
6 mo 7.8 11.6 0.61
12 mo 21.4 17.3 0.31
Mental health D/C 2.2 2.0 0.95 0.025
6 mo 0.9 1.6 0.63
12 mo 1.5 1.0 0.41
ADL scores
Basic D/C 0.7 1.3 0.003 0.0056
6 mo 0.9 1.3 0.17
12 mo 0.8 1.1 0.24
Instrumental D/C 1.6 1.6 0.98 0.05
6 mo 0.9 1.1 0.91
12 mo 1.5 1.2 0.37
ADL ¼ activity of daily living; D/C ¼ discharge; GEM ¼ geriatric management;
HF ¼ heart failure; SF-36 ¼ Medical Outcomes Study 36-Item Short-Form General
Health Survey.
a Mean scores shown are unadjusted for length of stay and baseline status. Higher
scores are indicative of better function.
b p values are for between-group differences of mean changes in scores and are
adjusted.
c The Holm procedure ﬁrst ranks the 10 p values from lowest to highest. The ﬁrst
(lowest) p value has to be less than 0.0056 (0.05/9) to be statistically signiﬁcant
and to permit continuation to the other t tests. The Holm procedure continues
sequentially in this fashion using a levels of 0.0063 (0.05/8), 0.0071 (0.05/7). 0.05
(0.05/1) for the remaining six tests, respectively. The primary outcome (physical
function) is not considered under the testing of multiple secondary outcomes. The
Holm procedure p values presented here are for mean change at discharge only, as
p values at 6 months and 1 year were not signiﬁcant.
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mortality curves demonstrated no difference in 1-year mortality
between groups (29.0% in GEM and 27.3% in UC; p ¼ 0.73) (Fig. 1).
Patients in GEM had a greater mean length of stay during the index
hospitalization compared to UC (24 vs. 17 days, p ¼ 0.03).
We observed no signiﬁcant differences in total costs between
management strategies after log transformation of costs due to
non-normal distribution. Neither the parametric t test (of trans-
formed data, p ¼ 0.90) nor the nonparametric Wilcoxon rank-sum
test (p ¼ 0.89) detected differences in total costs between the
groups.
4. Discussion
Hospitalized older veterans with a history of HF were at high
risk for functional decline, as evidenced by baseline SF-36 scores
and functional disabilities. The study population was also charac-
terized by multimorbidity (average Charlson index of 3.8) with
nearly a 30% mortality rate at 1 year post randomization. After
adjusting for baseline differences, our ﬁndings suggested that the
GEM strategy, as compared with UC, was associated with greater
preservation of physical function and basic ADLs from baseline to
the time of hospital discharge. Other HRQOL domains measured by
the SF-36 subscales also trended favorably for GEM but did not
reach statistical signiﬁcance. There were no observed differences in
the survival rate between the GEM group and the UC group, and
early improvements in physical function and basic ADLs seen with
GEM group at hospital discharge were not sustained at 1 year.
Importantly, there were no observed outcomes for which GEM was
a less desirable strategy than UC, including no difference in total
cost between the two strategies. Given the prevalence of HF in the
community, coexisting multimorbidities in older HF patients,
associated costs, and recognized consequences from traditional
hospitalization, inpatient GEM may represent an alternative care
paradigm for arresting decline in functional capacity prior to
transitioning patients from the hospital setting to the community.
We believe that the early short-term beneﬁt observed may have
been attributed to improved recognition of clinical conditions that
were then targeted for evaluation and management, a character-
istic feature of the GEM strategy8,12,17. Such interventions may have
included improved pharmacotherapy optimization, reﬁnement of
physical therapy exercises toward individualized goals, and patient
education regarding their medical ailments and techniques to
promote health education. Our observation that GEM, as compared
with UC, was associated with better preservation of functionalFig. 1. KaplaneMeier mortality curve for frail older adults with a history of HF by
inpatient treatment group assignment. C-C-C represents inpatient GEM and Δ-Δ-Δ
represents UC. GEM ¼ geriatric management; HF ¼ heart failure; UC ¼ usual care.reserves in basic ADLs at the time of hospital discharge has
important implications. It has previously been shown that func-
tional decline in hospitalized patients is associated with rehospi-
talization, institutionalization, and mortality1,2,4,27. Improvement in
physical function and reduced disability in older adults with HF at
the time of hospital discharge may be functional biomarkers that
could be associated with better outcomes6,7. Absence of sustained
beneﬁts using GEM, as observed in our study, has also been noted in
previously published studies8,9,28 and remains poorly understood.
Although the downward spiral of the frailty syndrome was not
attenuated over the long term after inpatient GEM in our study, it
may be possible to reinforce inpatient GEMmanagement strategies
longitudinally in an effort to maintain functional reserves and
adaptive capacity in older adults at high risk for clinical deterio-
ration. Therefore, one possibility of a lack of observed lasting
beneﬁt of the GEM approach for physical function and ADLs was the
absence of periodic intensive assessments to identify, target, and
manage functional deﬁciencies and health decline. Efforts to
understand alternative health-care delivery strategies to care for
the growing sector of older adults with frailty and comorbid clinic
conditions, including the bulk of patients with chronic HF, require
an integrated and goal-directed management plan that improves
upon current GEM delivery models6,13,14,29. The use of disease
management programs as adjunctivemanagement strategies in the
care of high-risk HF patients is becoming increasingly common7,30,
and it has been suggested that implementation of disease
management strategies should engage researchers, policy makers,
and payers toward addressing this unmet need in outpatient
HF management10. What remains to be determined is whether
strategies targeted to improve patient functional status through
conditioning and reconditioning therapies can be applied to the
hospitalized vulnerable older adult and also be translated to
improvements in important health outcomes.
Our study has limitations. We were unable to validate HF
disease severity or examine the existence of a temporal relationship
between HF symptoms and hospitalization. In addition, we did not
have information regarding left ventricular systolic function or New
York Heart Association functional class, both of which have inde-
pendent prognostic value in HF6. We used ICD-9 codes for HF as
entry criteria for this study, representing a population of patients
who had previously received a diagnosis of HF by a health-care
provider. The use of ICD-9 codes to identify a cohort of patients
with HF has previously been validated and reported in the litera-
ture31. By selecting frail older patients hospitalized with a prior
history of clinical HF, we included a cohort of patients who were at
high risk for future adverse clinical outcomes and a population that
is commonly encountered in clinical settings5,6,11,14. Findings from
the Cardiovascular Health Study, an observational study that
included 5201 patients aged 65 and older and was designed to
determine the risk factors for and consequences of cardiovascular
disease in older adults, demonstrated that of the 78 patient
characteristics studied, the only medical condition in the clinical
history that was a signiﬁcant predictor of mortality in multivariate
analysis was a clinical history of HF32. Our study was also limited by
sample size and may have limited our ability to detect clinically
important differences in HRQOL at 1 year. However, we included all
patients from the parent trial with a prior diagnosis of HF (n¼ 309)
in our analysis, and the follow-up in the original trial was near
complete with 99% of all planned telephone follow-up interviews
having been conducted successfully9.
We observed a greater length of stay for patients in GEM
compared to UC. We believe that this ﬁnding is likely related to the
additional time investment for multidisciplinary assessment,
intervention, and management. This increase in length of stay
occurred at no signiﬁcant increase in total costs over the course of
S.M. Gharacholou et al.116a full year. There may have been unmeasured beneﬁcial effects in
early transition to inpatient GEM after resolution of acute illness
compared with ongoing inpatient hospitalization with its associ-
ated risks of adverse outcomes among vulnerable elders. The effect
of inpatient transition to GEM versus UC prior to hospital discharge
has previously demonstrated reduced disability and less institu-
tionalization8 but may also reduce adverse in-hospital events (e.g.,
delirium, falls, and errors) and should be investigated in future
studies.
Frail adults are at high risk for adverse clinical outcomes, and
strategies to attenuate functional, psychological, and general health
decline remain an important area of ongoing research in geron-
tology24. The care of frail older adults with HF in practice is often
underscored by complicated issues of polypharmacy, depression,
high resource utilization, and functional decline. Studies evaluating
optimal management strategies for elderly HF patients may require
an amalgam of advances in GEM in consort with evidence-based HF
therapy that optimizes transition from hospital to community with
less perturbation. Care models, such as inpatient GEM, that aim at
speciﬁcally improving functional outcomes and reducing disability
after hospitalization among frail adults with chronic HF should
be actively investigated given the public health and health policy
implications.
5. Conclusions
Frail older adults with a history of HF derived greater short-term
beneﬁts utilizing an inpatient GEM strategy as compared with UC.
No differences in HRQOL or survival were observed between GEM
and UC at 1 year post randomization. Multidisciplinary models of
care, of which the GEM approach has previously been studied, may
be important given the high rates of hospitalizations, functional
decline, and readmissions in older adults with comorbidities.
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